Postbiotics (General) for Immune Function

Research suggests that postbiotics and related microbiome-derived compounds may play a meaningful role in modulating immune function, with a 2023 review proposing that these bioactive compounds hold promise as next-generation therapeutic agents capable of influencing gut-immune communication and correcting immune imbalances. The available evidence base here consists of one narrative review and two exploratory animal or observational studies, none of which directly tested postbiotic supplementation for immune outcomes in healthy humans, which substantially limits the strength of any conclusions. The two non-review studies, while touching on related microbiome and immune themes such as neuroinflammation and infection susceptibility in liver disease, did not test postbiotics directly and produced largely neutral or preliminary findings. Overall, the research is early-stage and directionally promising but lacks the randomized controlled trials or clinical data needed to draw firm conclusions about the efficacy of postbiotics for supporting immune function in humans.